To the full analysis
Privia Health Group stock: growth
PRVAPrivia Health Group reported $2.12B in revenue for fiscal 2025, up 22.3% on the prior year, up 21% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
18.2%
per year from 2018 to 2025, per share 15.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
64.3%
per year from 2018 to 2025, per share 60.2%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2018 | |
|---|---|---|
| Revenue | 21.0% | 18.2% |
| Revenue per share | 17.6% | 15.3% |
| Earnings | −6.0% | no data |
| Earnings per share | −8.7% | no data |
| Free cash flow | 33.3% | 64.3% |
| Free cash flow per share | 29.5% | 60.2% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2018 | $657.61M | −$3.04M | $5.03M |
| 2019 | $786.36M | $8.24M | $18.65M |
| 2020 | $817.08M | $31.24M | $38.51M |
| 2021 | $966.22M | −$188.23M | $54.51M |
| 2022 | $1.36B | −$8.59M | $47.09M |
| 2023 | $1.66B | $23.08M | $80.67M |
| 2024 | $1.74B | $14.39M | $104.26M |
| 2025 | $2.12B | $22.92M | $162.2M |
Revenue by segment
How Privia Health Group, Inc. makes its money and how that has shifted. Names are as the company reports them.
- FFS-Patient Care64%
- Capitated Revenue15%
- Shared Savings11%
- FFS-Administrative Services6%
- Care Management Fee (PMPM)3%
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| FFS-Patient Care | $869.17M | $976.69M | $1.15B | $1.36B | 64.1% |
| Capitated Revenue | $218.46M | $338.73M | $212.99M | $308.46M | 14.5% |
| Shared Savings | $132.62M | $170.14M | $179.2M | $234.82M | 11.1% |
| FFS-Administrative Services | $94.93M | $113.15M | $125.43M | $137.02M | 6.5% |
| Care Management Fee (PMPM) | $35.54M | $50.52M | $64.07M | $73.14M | 3.4% |
| Total revenue | $1.36B | $1.66B | $1.74B | $2.12B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 5 Nov 2026)
- Valuation signal Fairly valued since 12 Nov 2026, previously Overvalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.